CLLS US Equity

Cellectis S.A.

Health Care · Biological Products, (No Diagnostic Substances) · CIK 1627281 · FY ends Dec 31

$3.17

+0.13 (+4.28%)

USD · as of 2026-08-19 · marketstack

Switch Ticker

Events

0 8-K filings · 0 13D · 0 13G

Date

Event

What happened / filer

Source

No 8-K or Schedule 13D/G filings on record for CLLS in the collected window (US SEC filers only).

Source: SEC EDGAR (public domain)

Every row is a filed document, checked against its EDGAR index.